Birdwatch Note Rating
2023-03-16 00:42:44 UTC - HELPFUL
Rated by Participant: FF73A40573CB5B64B421F841B10598542242FCD8D76C969F3F1E9FB41D8411E4
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details